690
Views
26
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Autoimmune pancreatitis

&
Pages 1391-1407 | Received 20 Jun 2009, Accepted 22 Sep 2009, Published online: 03 Dec 2009

References

  • Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991;22:387–95.
  • Ball WP, Baggenstoss AH, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol (Chic) 1950;50:347–58.
  • Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas–-an autonomous pancreatic disease? Am J Dig Dis 1961;6:688–98.
  • Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119–27.
  • Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006;30:1537–45.
  • Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561–8.
  • Chari ST, Singer MV. The problem of classification and staging of chronic pancreatitis. Proposals based on current knowledge of its natural history. Scand J Gastroenterol 1994;29:949–60.
  • Ectors N, Maillet B, Aerts R, Geboes K, Donner A, Borchard F, Non-alcoholic duct destructive chronic pancreatitis. Gut 1997;41:263–8.
  • Gardner TB, Chari ST. Autoimmune pancreatitis. Gastroenterol Clin North Am 2008;37:439–60.
  • Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003;27:1–13.
  • Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR, Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007;102:2417–25.
  • Kamisawa T, Funata N, Hayashi Y, Tsuruta K, Okamoto A, Amemiya K, Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003;52:683–7.
  • Kleeff J, Welsch T, Esposito I, Löhr M, Singer R, Büchler MW, [Autoimmune pancreatitis–-a surgical disease?]. Chirurg 2006;77:154–65.
  • Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–8.
  • Detlefsen S, Sipos B, Zhao J, Drewes AM, Klöppel G. Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors. Am J Surg Pathol 2008;32:986–95.
  • Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552–63.
  • Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006;41:613–25.
  • Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009;4 May [Epub ahead of print].
  • Moon SH, Kim MH, Park DH, Hwang CY, Park SJ, Lee SS, Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008;57:1704–12.
  • Löhr M, Klöppel G. [Indications for pancreatic biopsy. Uncommon, but increasingly more important]. Pathologe 2005;26:67–72.
  • Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007;42 Suppl 186–8.
  • Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’? Am J Surg Pathol 2003;27:110–20.
  • Weber SM, Cubukcu-Dimopulo O, Palesty JA, Suriawinata A, Klimstra D, Brennan MF, Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003;7:129–37.
  • Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605–16.
  • Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas 2003;27:14–19.
  • Klöppel G. Chronic pancreatitis, pseudotumors and other tumor-like lesions. Mod Pathol 2007;20 Suppl 1S113–31.
  • Detlefsen S, Drewes AM, Vyberg M, Klöppel G. Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch 2009;454:531–9.
  • Uchida K, Yazumi S, Nishio A, Kusuda T, Koyabu M, Fukata M, Long-term outcome of autoimmune pancreatitis. J Gastroenterol 2009;44:726–32.
  • Børkje B, Vetvik K, Odegaard S, Schrumpf E, Larssen TB, Kolmannskog F. Chronic pancreatitis in patients with sclerosing cholangitis and ulcerative colitis. Scand J Gastroenterol 1985;20:539–42.
  • Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1–4.
  • Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Extrapancreatic lesions in autoimmune pancreatitis. J Clin Gastroenterol 2005;39:904–7.
  • Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000;356:910–1.
  • Kamisawa T, Anjiki H, Egawa N. Rapid changes in sclerosing cholangitis associated with autoimmune pancreatitis. Pancreas 2009;38:601–2.
  • Kamisawa T, Takuma K, Anjiki H, Egawa N, Kurata M, Honda G, Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol 2009;15:2357–60.
  • Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis–-Overlapping or separate diseases? J Hepatol 2009;51:398–402.
  • Montefusco PP, Geiss AC, Bronzo RL, Randall S, Kahn E, McKinley MJ. Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex. Am J Surg 1984;147:822–6.
  • Sood S, Fossard DP, Shorrock K. Chronic sclerosing pancreatitis in Sjögren's syndrome: a case report. Pancreas 1995;10:419–21.
  • Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol Res 2007;37 Suppl 3S478–86.
  • Nishino T, Oyama H, Hashimoto E, Toki F, Oi I, Kobayashi M, Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis. J Gastroenterol 2007;42:550–9.
  • Tsushima K, Tanabe T, Yamamoto H, Koizumi T, Kawa S, Hamano H, Pulmonary involvement of autoimmune pancreatitis. Eur J Clin Invest 2009;39(8):714–22.
  • Hirano K, Kawabe T, Komatsu Y, Matsubara S, Togawa O, Arizumi T, High-rate pulmonary involvement in autoimmune pancreatitis. Intern Med J 2006;36:58–61.
  • Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, Autoimmune pancreatitis: imaging features. Radiology 2004;233:345–52.
  • Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 2004;43:18–25.
  • Imai H, Hamai K, Komatsuda A, Ohtani H, Miura AB. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int 1997;51:270–6.
  • Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol 2009;71:173–8.
  • de Suray N, Van Beers B, Sempoux C, Borschette C, Lonneux M, Deprez P. Autoimmune pancreatitis, sclerosing cholangitis, liver inflammatory pseudotumors, retroperitoneal fibrosis, lymphadenopathy, and sialoadenitis in a single patient: a multifaceted expression of a hitherto unrecognized systemic autoimmune syndrome? Pancreas 2009;38:476–8.
  • Kamisawa T, Imai M, Egawa N, Tsuruta K, Okamoto A. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2008;20:1167–70.
  • Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006;41:1197–205.
  • Kawa S, Hamano H. Assessment of serological markers for the diagnosis of autoimmune pancreatitis. J Jpn Pancreas Soc 2003;17:607–10.
  • Choi EK, Kim MH, Lee TY, Kwon S, Oh HC, Hwang CY, The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007;35:156–61.
  • Aparisi L, Farre A, Gomez-Cambronero L, Martinez J, De Las HG, Corts J, Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005;54: 703–9.
  • Nahon UK, Levy P, O'Toole D, Belmatoug N, Vullierme MP, Couvelard A, Is idiopathic chronic pancreatitis an autoimmune disease? Clin Gastroenterol Hepatol 2005;3:903–9.
  • Löhr M. What are the useful biological and functional markers of early-stage chronic pancreatitis? J Gastroenterol 2007;42 Suppl 17: 66–71.
  • Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650–2.
  • Hirano K, Kawabe T, Yamamoto N, Nakai Y, Sasahira N, Tsujino T, Serum IgG4 concentrations in pancreatic and biliary diseases. Clin Chim Acta 2006;367:181–4.
  • Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity ‘autoimmune pancreatitis-associated sclerosing cholangitis’. Pathol Int 2005;55:405–11.
  • Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6:132–7.
  • Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009;24:15–36.
  • Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Morphological changes after steroid therapy in autoimmune pancreatitis. Scand J Gastroenterol 2004;39:1154–8.
  • Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006;45:497–501.
  • Umemura T, Zen Y, Hamano H, Kawa S, Nakanuma Y, Kiyosawa K. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007;46:463–71.
  • Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573–81.
  • Esposito I, Born D, Bergmann F, Longerich T, Welsch T, Giese NA, Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. PLoS ONE 2008;3:2539.
  • Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol 2008;43:609–13.
  • Irie H, Honda H, Baba S, Kuroiwa T, Yoshimitsu K, Tajima T, Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998;170:1323–7.
  • Procacci C, Carbognin G, Biasiutti C, Frulloni L, Bicego E, Spoto E, Autoimmune pancreatitis: possibilities of CT characterization. Pancreatology 2001;1:246–53.
  • Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006;355:2670–6.
  • Fukumori K, Shakado S, Miyahara T, Fukuizumi K, Takemoto R, Nishi H, Atypical manifestations of pancreatitis with autoimmune phenomenon in an adolescent female. Intern Med 2005;44:886–91.
  • Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494–9.
  • Nakazawa T, Ohara H, Sano H, Aoki S, Kobayashi S, Okamoto T, Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 2004;60:937–44.
  • Farrell JJ, Garber J, Sahani D, Brugge WR. EUS findings in patients with autoimmune pancreatitis. Gastrointest Endosc 2004;60:927–36.
  • Catalano MF, Sahai A, Levy M, Romagnuolo J, Wiersema M, Brugge W, EUS-based criteria for the diagnosis of chronic pancreatitis: the Rosemont classification. Gastrointest Endosc 2009;69:1251–61.
  • Hoki N, Mizuno N, Sawaki A, Tajika M, Takayama R, Shimizu Y, Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 2009;44:154–9.
  • Sahai AV, Zimmerman M, Aabakken L, Tarnasky PR, Cunningham JT, van Velse A, Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc 1998;48:18–25.
  • Salla C, Chatzipantelis P, Konstantinou P, Karoumpalis I, Pantazopoulou A, Tsiotos G. EUS-FNA contribution in the identification of autoimmune pancreatitis: a case report. JOP 2007;8:598–604.
  • Deshpande V, Mino-Kenudson M, Brugge WR, Pitman MB, Fernandez-del CC, Warshaw AL, Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol 2005;29:1464–71.
  • Nakamoto Y, Saga T, Ishimori T, Higashi T, Mamede M, Okazaki K, FDG-PET of autoimmune-related pancreatitis: preliminary results. Eur J Nucl Med 2000;27:1835–8.
  • Ozaki Y, Oguchi K, Hamano H, Arakura N, Muraki T, Kiyosawa K, Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 2008;43:144–51.
  • Lee TY, Kim MH, Park DH, Seo DW, Lee SK, Kim JS, Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 2009;193:343–8.
  • Klöppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 2007;42 Suppl 18 28–31.
  • Zamboni G, Capelli P, Pesci A, Beghelli S, Lüttges J, Klöppel G. Pancreatic head mass: what can be done? Classification: the pathological point of view JOP 2000;1:77–84.
  • Zamboni G, Capelli P, Scarpa A, Bogina G, Pesci A, Brunello E, Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med 2009;133:439–53.
  • Kajiwara M, Gotohda N, Konishi M, Nakagohri T, Takahashi S, Kojima M, Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: Experience of a single tertiary cancer center. Scand J Gastroenterol 2008;43:110–16.
  • Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004;28:1193–203.
  • Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Fibrogenesis in alcoholic chronic pancreatitis: the role of tissue necrosis, macrophages, myofibroblasts and cytokines. Mod Pathol 2006;19:1019–26.
  • Detlefsen S, Sipos B, Feyerabend B, Klöppel G. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005;447:800–5.
  • Klöppel G, Lüttges J, Sipos B, Capelli P, Zamboni G. Autoimmune pancreatitis: pathological findings. JOP 2005;6:97–101.
  • Suda K, Takase M, Fukumura Y, Kashiwagi S. Pathology of autoimmune pancreatitis and tumor-forming pancreatitis. J Gastroenterol 2007;42 Suppl 18 22–7.
  • Klöppel G, Detlefsen S, Feyerabend B. Fibrosis of the pancreas: the initial tissue damage and the resulting pattern. Virchows Arch 2004;445:1–8.
  • Kojima M, Sipos B, Klapper W, Frahm O, Knuth HC, Yanagisawa A, Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J Surg Pathol 2007;31:521–8.
  • Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23–28.
  • Hochwald SN, Hemming AW, Draganov P, Vogel SB, Dixon LR, Grobmyer SR. Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution. Ann Surg Oncol 2008;15:1147–54.
  • Bang SJ, Kim MH, Kim DH, Lee TY, Kwon S, Oh HC, Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas 2008;36:84–9.
  • Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010–16.
  • Deshpande V, Mino-Kenudson M, Brugge W, Lauwers GY. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology Arch Pathol Lab Med 2005;129:1148–54.
  • Levy MJ, Wiersema MJ, Chari ST. Chronic pancreatitis: focal pancreatitis or cancer? Is there a role for FNA/biopsy? Autoimmune pancreatitis. Endoscopy 2006;38 Suppl 1S30–35.
  • Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki N, Hara K, Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009;44(7):742–50.
  • Hirano K, Fukushima N, Tada M, Isayama H, Mizuno S, Yamamoto K, Diagnostic utility of biopsy specimens for autoimmune pancreatitis. J Gastroenterol 2009;44:765–73.
  • Andersson R, Tingstedt B, Xia J. Pathogenesis of chronic pancreatitis: a comprehensive update and a look into the future. Scand J Gastroenterol 2009;44:661–3.
  • Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538–46.
  • Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002;122:1264–9.
  • Taniguchi T, Okazaki K, Okamoto M, Seko S, Tanaka J, Uchida K, High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 2003;27:26–30.
  • Aoki S, Nakazawa T, Ohara H, Sano H, Nakao H, Joh T, Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 2005;47:147–58.
  • Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000;95:2788–94.
  • Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, Ohana M, Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 2002;82:411–24.
  • Endo T, Takizawa S, Tanaka S, Takahashi M, Fujii H, Kamisawa T, Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes. Diabetes 2009;58:732–7.
  • Takizawa S, Endo T, Wanjia X, Tanaka S, Takahashi M, Kobayashi T. HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes. Biochem Biophys Res Commun 2009;386:192–6.
  • Umemura T, Katsuyama Y, Hamano H, Kitahara K, Takayama M, Arakura N, Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis. Hum Immunol 2009;70:742–6.
  • Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007;31:1586–97.
  • Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis. J Jpn Pancreas Soc 2002;17:585–7.
  • Okazaki K, Uchida K, Matsushita M, Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007;42 Suppl 1832–8.
  • Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006;12:2487–96.
  • Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008;43:403–8.
  • Kamisawa T, Satake K. Therapeutic strategy for autoimmune pancreatitis. Adv Med Sci 2008;53(2):145–8.
  • DiMagno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastroenterol 2009;25:454–9.
  • Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626–31.
  • Ghazale A, Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007;102:1646–53.
  • Raina A, Krasinskas AM, Greer JB, Lamb J, Fink E, Moser AJ, Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008;132:48–53.
  • Levy P, Hammel P, Ruszniewski P. Diagnostic challenge in autoimmune pancreatitis: beware of shipwreck!. Gut 2008;57:1646–7.
  • Ito T, Nishimori I, Inoue N, Kawabe K, Gibo J, Arita Y, Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007;42 Suppl 18 50–8.
  • Saito T, Tanaka S, Yoshida H, Imamura T, Ukegawa J, Seki T, A case of autoimmune pancreatitis responding to steroid therapy. Evidence of histologic recovery. Pancreatology 2002;2:550–6.
  • Fernandez-del Castillo CF, Sahani DV, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med 2003;349:893–901.
  • Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234–8.
  • Ozden I, Dizdaroglu F, Poyanli A, Emre A. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology 2005;5:300–3.
  • Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Sawabu N. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas 2005;30:31–9.
  • Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007;56:1719–24.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.